Recent Quotes (30 days)

You have no recent quotes
chg | %

GlaxoSmithKline plc news

   Watch this stock
Showing stories 1 - 10 of about 124   

Articles published

GSK 1,701.51 +5.01 (0.30%)
price chart
Should you buy GlaxoSmithKline plc after today's results?
GlaxoSmithkline (LSE: GSK) has suffered four years of falling earnings as, along with FTSE 100 competitor AstraZeneca, it faced the loss of patents on some key drugs and a resulting increase in competition from generic alternatives.
GlaxoSmithKline plc (NYSE:GSK) To Invest $360 Million In Britain Amid Brexit ...
GlaxoSmithKline plc (NYSE:GSK) is planning to inject $360.3 million (�275 million) in three Britain-based plants following the surprising boost it experienced post-Brexit.
GlaxoSmithKline upbeat despite currency hit  Proactive Investors UK
Stock Earnings Estimates in Limelight: GlaxoSmithKline plc (ADR) (NYSE:GSK)  Post Registrar
GlaxoSmithKline plc (GSK) Earns Neutral Rating from JPMorgan Chase & Co.
GlaxoSmithKline plc logo GlaxoSmithKline plc (LON:GSK)'s stock had its “neutral” rating reissued by research analysts at JPMorgan Chase & Co.
Footsie perks up after shot in arm from Glaxosmithkline  Proactive Investors UK
S&P Global Inc. Analysts Give GlaxoSmithKline plc (GSK) a GBX 1650 Price ...  The Cerbat Gem
Analyst's Stocks Ratings Trend: GlaxoSmithKline PLC (NYSE:GSK) , Arena ...
On 7/27/2016, shares of GlaxoSmithKline PLC (NYSE:GSK) rose +2.17% in trading session and finally closed at $45.12. The company most recent volume stood at 6.01 million shares as compared to average volume of 3.51 million shares.
GlaxoSmithKline PLC (GSK) Receives Buy Rating from Goldman Sachs Group Inc.  Community Financial News
GlaxoSmithKline plc (GSK) Stock Rating Reaffirmed by Bryan, Garnier & Co  BBNS
Earnings Expectations Overview: The Blackstone Group L.P. (NYSE:BX ...
Last Trade: The Company closed its last session at $27.5 with the loss of -0.61%. The market capitalization of the company is $32.09 Billion, with the average Volume of 4.4 Million.
GlaxoSmithKline plc (ADR) Earning Release; Here's What to Expect
The UK-based pharmaceutical company, GlaxoSmithKline plc (ADR) (NYSE:GSK), is expected to announce second quarter (2Q) earnings result on July 27.
Brace yourself for interest rate cuts with GlaxoSmithKline plc, National Grid ...
With the uncertainty from Brexit already affecting the UK economy, it's looking likely that interest rates will be cut in the near future.
Will GlaxoSmithKline plc and AstraZeneca plc continue to be Brexit winners?
AstraZeneca converts its dividends into pence on the day it posts its results and if the pound stays, low future payouts will be worth more.
Analyst Rating Fluctuations to Observe: GlaxoSmithKline PLC (NYSE:GSK ...
GlaxoSmithKline PLC (NYSE:GSK) accumulated +0.27%, closing at $44.16 after floating between $43.91 and $44.41. The company has market capitalization of $107.26B.
Hamlin Capital Management, LLC Buys A Little More GlaxoSmithKline PLC Common ...  Finance Daily
GlaxoSmithKline plc Beats on Revenue; Invests in New Respiratory Drug
GlaxoSmithKline plc. (ADR) (NYSE:GSK) purchased global rights to an early-stage respiratory drug from Johnson & Johnson (NYSE:JNJ) for up to $230 million, or 175 million pounds, today.